These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6221579

  • 21. The alterative effect of isobutylmethylxanthine in hypofunctional human neutrophil chemotaxis.
    Debski BF, Ranney RR, Carchman RA.
    Biochem Biophys Res Commun; 1982 Oct 15; 108(3):1228-34. PubMed ID: 6185116
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease.
    Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF.
    J Periodontol; 1981 Aug 15; 52(8):410-5. PubMed ID: 7021793
    [No Abstract] [Full Text] [Related]

  • 23. Chemotaxis in vitreous haemorrhage: an experimental study.
    LaNauze JH, Hembry RM, Jacobson W, Watson PG.
    Exp Eye Res; 1982 May 15; 34(5):803-13. PubMed ID: 7084341
    [No Abstract] [Full Text] [Related]

  • 24. Phospholipase A2 and lipocortin effects.
    Dennis EA, Davidson FF.
    Prog Clin Biol Res; 1990 May 15; 349():47-54. PubMed ID: 2144646
    [No Abstract] [Full Text] [Related]

  • 25. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG, Brown PD.
    Am J Vet Res; 1982 Apr 15; 43(4):613-6. PubMed ID: 7073083
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Calcium-phospholipid interactions in secretory cells: a new perspective on stimulus-secretion coupling.
    Rubin RP.
    Fed Proc; 1982 Apr 15; 41(6):2181-7. PubMed ID: 6281077
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG, Keeling PJ, Henson PM.
    J Immunol; 1981 Dec 15; 127(6):2241-5. PubMed ID: 7053244
    [Abstract] [Full Text] [Related]

  • 30. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C, Fehr J.
    J Clin Invest; 1980 Nov 15; 66(5):884-91. PubMed ID: 7430350
    [Abstract] [Full Text] [Related]

  • 31. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA, Showell HJ, Freer RJ, Becker EL.
    J Immunol; 1982 Feb 15; 128(2):956-62. PubMed ID: 7033385
    [Abstract] [Full Text] [Related]

  • 32. Association of I-J determinants with lipomodulin/macrocortin.
    Jardieu P, Akasaki M, Ishizaka K.
    Proc Natl Acad Sci U S A; 1986 Jan 15; 83(1):160-4. PubMed ID: 2417235
    [Abstract] [Full Text] [Related]

  • 33. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D, Roloff JS, Lukens JN.
    J Immunol; 1981 Jan 15; 126(1):165-71. PubMed ID: 6256437
    [No Abstract] [Full Text] [Related]

  • 34. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
    Schleimer RP, Freeland HS, Peters SP, Brown KE, Derse CP.
    J Pharmacol Exp Ther; 1989 Aug 15; 250(2):598-605. PubMed ID: 2547940
    [Abstract] [Full Text] [Related]

  • 35. Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils.
    Rao KM, Varani J.
    J Immunol; 1982 Oct 15; 129(4):1605-7. PubMed ID: 6286771
    [Abstract] [Full Text] [Related]

  • 36. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
    Opitz W, Fruchtmann R.
    Hoppe Seylers Z Physiol Chem; 1981 Aug 15; 362(8):1037-41. PubMed ID: 7346374
    [Abstract] [Full Text] [Related]

  • 37. Lipocortins as antiphospholipase A2 and anti-inflammatory proteins.
    Russo-Marie F.
    Adv Exp Med Biol; 1990 Aug 15; 279():197-210. PubMed ID: 2151415
    [No Abstract] [Full Text] [Related]

  • 38. Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin.
    Hirata F, Notsu Y, Iwata M, Parente L, DiRosa M, Flower RJ.
    Biochem Biophys Res Commun; 1982 Nov 16; 109(1):223-30. PubMed ID: 7159423
    [No Abstract] [Full Text] [Related]

  • 39. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat.
    Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Langham CS, Parente L, Persico P, Russel-Smith NC, Stone D.
    Br J Pharmacol; 1982 May 16; 76(1):185-94. PubMed ID: 6282373
    [Abstract] [Full Text] [Related]

  • 40. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ, Day AR, Muthukumaraswamy N, Showell HJ, Becker EL.
    Kroc Found Ser; 1981 May 16; 14():161-8. PubMed ID: 6947071
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.